The pills have to be started as soon as possible, within five days of the start of symptoms.

US pharma giant Pfizer's combination of nirmatrelvir and ritonavir was the "superior choice" of treatment for unvaccinated, elderly or immu...

The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...

Although Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...

Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...

The SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, ...

The EMA's review of Merck's pill, developed with Ridgeback Biotherapeutics, is taking longer than Pfizer's because Merck released trial dat...

You'll need a prescription first from a doctor or other authorized health worker.

Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a cl...

Data from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...

The Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...

The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...

Pfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, ...

The nearing end of Pfizer's patent will open floodgates of the lucrative US market to Indian companies.

Pfizer recalled 1 mn birth-control packs after discovering that pills were mixed up inside the packages, possibly putting women at risk.

Pfizer Inc has agreed to license an array of generic pills and injectable medicines from India's Aurobindo Pharma Ltd as the world's larges...

Ranbaxy’s $12bn dream to bust Pfizer’s monopoly over its cholesterol-lowering pill Lipitor has suffered yet another setback with the US Cou...